Peer Review History
| Original SubmissionAugust 4, 2025 |
|---|
|
Dear Dr. Boelens, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. Please note that we have only been able to secure a single reviewer to assess your manuscript. We are issuing a decision on your manuscript at this point to prevent further delays in the evaluation of your manuscript. Please be aware that the editor who handles your revised manuscript might find it necessary to invite additional reviewers to assess this work once the revised manuscript is submitted. However, we will aim to proceed on the basis of this single review if possible. Please submit your revised manuscript by Nov 28 2025 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Vanessa Carels Staff Editor PLOS ONE Journal requirements: When submitting your revision, we need you to address these additional requirements. 1. Please ensure that your manuscript meets PLOS ONE's style requirements, including those for file naming. The PLOS ONE style templates can be found at https://journals.plos.org/plosone/s/file?id=wjVg/PLOSOne_formatting_sample_main_body.pdf and 2. Thank you for stating the following in the Funding Section of your manuscript: “This work was funded by a research grant (project number: 10530012110002) from ZonMw, The Netherlands Organization for Health Research and Development(https://www.zonmw.nl/en). ZonMw has no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.” We note that you have provided funding information that is currently declared in your Funding Statement. However, funding information should not appear in the Acknowledgments section or other areas of your manuscript. We will only publish funding information present in the Funding Statement section of the online submission form. Please remove any funding-related text from the manuscript and let us know how you would like to update your Funding Statement. Currently, your Funding Statement reads as follows: “his work was funded by a research grant (project number: 10530012110002) from ZonMw, The Netherlands Organization for Health Research and Development (https://www.zonmw.nl/en). ZonMw has no role in the study design, data collection and analysis, decision to publish or preparation of the manuscript.” Please include your amended statements within your cover letter; we will change the online submission form on your behalf. 3. In the online submission form you indicate that your data is not available for proprietary reasons and have provided a contact point for accessing this data. Please note that your current contact point is a co-author on this manuscript. According to our Data Policy, the contact point must not be an author on the manuscript and must be an institutional contact, ideally not an individual. Please revise your data statement to a non-author institutional point of contact, such as a data access or ethics committee, and send this to us via return email. Please also include contact information for the third party organization, and please include the full citation of where the data can be found. 4. Please include captions for your Supporting Information files at the end of your manuscript, and update any in-text citations to match accordingly. Please see our Supporting Information guidelines for more information: http://journals.plos.org/plosone/s/supporting-information. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author 1. Is the manuscript technically sound, and do the data support the conclusions? Reviewer #1: Yes ********** 2. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #1: N/A ********** 3. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #1: Yes ********** 4. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #1: Yes ********** Reviewer #1: 1. Study aim vs. design clarity The paper oscillates between instrument refinement and qualitative exploration of item content. Tighten the aim in Abstract/Introduction and align Methods/Results accordingly (e.g., “to refine the 32-item CPHQ for cross-domain use through stakeholder focus groups, expert review, and member checking, producing a 28-item version ready for psychometric testing”). 2. Sampling strategy and reflexivity Provide a more transparent account of purposive sampling: who identified participants, how invitations were distributed, and how diversity (domain, geography, SEP, gender) was ensured; add a brief table on recruitment sources and non-participation. Include researcher positionality/reflexivity and how it may have shaped facilitation and analysis (e.g., backgrounds of moderators, prior ties to Positive Health). This aligns with SRQR/COREQ good practice. 3. Focus group procedures and analytic rigour You describe two “rounds” (qualitative memos; sticker voting) plus thematic analysis and an adapted COMET decision rule. Please: Cite or append the exact decision rules and thresholds and justify the >50% / ≤15% cut-offs; explain how discordant groups were handled. Clarify how qualitative inputs (memos/transcripts) were integrated with sticker scores to decide retain/adjust/omit/merge at item level; a worked example for one contentious item would help. Report coder training, codebook development, intercoder agreement (if calculated) or processes to reach consensus. Move Table 2 (themes guiding adjustments) earlier and link each theme to concrete item changes. 4. Theoretical mapping to the Capability Approach The recategorization into resources, conversion factors, capabilities, functionings is a major conceptual move. Provide a short, a priori mapping framework (definitions + decision rules) and a few exemplars that were debated (e.g., “I feel safe where I live” vs. “I can be active in my environment”). Consider an expert agreement check for the taxonomy. 5. Language, readability, and cross-cultural validity You note items were developed in Dutch, translated to English by a native translator, with no back-translation. For an instrument intended for cross-domain and potentially cross-national use, justify the absence of back-translation and describe plans for formal linguistic validation and cognitive debriefing in future studies. Also, elaborate on how readability for low literacy was ensured beyond the PHAROS review (e.g., Flesch scores, cognitive interviewing). 6. Member check scope and interpretation Response rate was 33% (18/55). Discuss non-response bias and whether respondents differed from the original focus-group sample. Summarize what changed (if anything) after the member check, and justify keeping contested items (e.g., “I feel excluded” negative phrasing) beyond stating “no major concerns.” Consider a short table mapping member-check suggestions to disposition. 7. Political representation & trust items Decisions around removing “I feel represented by politics” but retaining “confidence in society” merit deeper justification, given prior factor structure in the original CPHQ and the Capability Approach emphasis on social conversion factors. Consider keeping both for psychometric testing, or provide empirical/analytic rationale for removal beyond stakeholder preference. 8. Data availability and transparency The current Data Availability Statement indicates restricted access due to privacy. Provide a stronger transparency plan (e.g., share de-identified sticker tallies, decision logs for each item in a public repository; provide the final 28-item instrument, Dutch + English, with response options). This aligns with PLOS ONE policy and will aid replication. Abstract: Report key numbers succinctly (10 FGDs; n=76; final 28 items; main themes guiding edits). Avoid method jargon (“adapted COMET”) without a one-line gloss. Methods: Specify focus-group duration per stakeholder type; clarify whether mixed-stakeholder groups were analyzed separately. Add example prompts and the “handbook” list to an SI. Results: Tables 3–5 are valuable. Add a column in Table 3 linking each edit to the qualitative theme and COMET outcome; indicate where “golden tickets” influenced decisions. Report descriptive characteristics per group consistently; a CONSORT-like flow for recruitment would help readability. Discussion: When noting the primacy of functionings items (“I feel healthy/happy/fit”), link this more explicitly to measurement implications (risk of redundancy with global health/QoL items; need to test higher-order factor). Expand on implications for monitoring population broad health vs. program evaluation, including sensitivity to change. Limitations: Acknowledge possible pro-Positive-Health sample bias; discuss implications of removing politically tinged items for construct coverage. Presentation: Fix small typos (“pronfessionals”, spacing), standardize item wording (all first-person present), and ensure the final 28-item list in Appendix 3 exactly matches Table 5 categories. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #1: No ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool, https://pacev2.apexcovantage.com/. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Registration is free. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email PLOS at figures@plos.org. Please note that Supporting Information files do not need this step. |
| Revision 1 |
|
Dear Dr. Boelens, Thank you for submitting your manuscript to PLOS ONE. After careful consideration, we feel that it has merit but does not fully meet PLOS ONE’s publication criteria as it currently stands. Therefore, we invite you to submit a revised version of the manuscript that addresses the points raised during the review process. ============================== The manuscript has been evaluated by two reviewers, and their comments are available below. While many of the concerns have been addressed, the reviewers have several remaining concerns. They note that there are ten focus groups listed in table 1 but nine focus groups described in the text. They would like justification for the focus group size. They also recommend defining terminology and suggest points that could be clarified for the reader. Could you please carefully revise the manuscript to address all comments raised? ============================== Please submit your revised manuscript by May 03 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. We look forward to receiving your revised manuscript. Kind regards, Katherine Demi Kokkinias, Ph.D. Staff Editor PLOS One Journal Requirements: If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. [Note: HTML markup is below. Please do not edit.] Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Yes Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: Yes Reviewer #3: No ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: My review comments are based on Revision 1 which includes multiple changes made in response to Reviewer 1's feedback. These changes have been substantively met, and no further changes are recommended. As noted by the authors, a well-designed patient-reported outcome measure is an important step in supporting the potential utility of positive health perspectives. The continued development of the CPHQ is an important step in this direction. Future research from independent research groups to clarify the reliability and validity of this measure will be an important outcome that this paper supports. Reviewer #3: Thank you for the opportunity to evaluate this manuscript. In this work, the authors aimed to refine the 32-item Context-sensitive Positive Health Questionnaire (CPHQ) for broader use across healthcare, welfare, and policy domains. Starting from the previously developed CPHQ, they conducted focus group discussions with stakeholders from healthcare, welfare, policy, and research, as well as with patients and citizens, including individuals with lower socioeconomic position. The study combined qualitative feedback and structured item scoring during the focus groups. Participants commented on the relevance, clarity, and formulation of questionnaire items, rated whether items should be retained, adjusted, or omitted, and identified particularly important items. Based on this process, the authors omitted, merged, reformulated, and added items, resulting in a revised set of 28 items. After the focus groups, the revised questionnaire was further examined through expert validation and a member check with a subgroup of original participants. The expert review contributed to additional refinements in item wording and supported the inclusion of some items that had been reconsidered as important for capturing broad health. The final set of items was then categorized according to the Capability Approach into resources, conversion factors, capabilities, and functionings. The final result of the study is a revised 28-item CPHQ, intended as a theory-informed and stakeholder-informed instrument to measure broad health, with future research needed for further validation and possible shortening. 1/ In the Objective sections of both the Abstract and Introduction, the manuscript alternates between “refine the 32-item CPHQ for cross-domain use,” “further improve the CPHQ-instrument,” and broader descriptions of exploring stakeholder perspectives. The manuscript would thus benefit from stating one stable objective formulation and using that exact wording throughout the manuscript to keep the design, analysis, and results aligned. 2/ In the Abstract (“We conducted focus group discussions (9 FGDs; n=76)”) and in the Methods/Table 1, where ten focus groups are listed (“Focus group 1” through “Focus group 10”), it seems that there is a mismatch in the reported number of FGDs. The manuscript would benefit from aligning the number of focus groups consistently across the Abstract, Methods, Results, and tables, and clarifying whether one group was excluded from a specific stage of analysis. 3/ In the FGD method subsection, the manuscript states that “Participants in each focus group were divided into groups of no more than five persons,” however no rationale is provided for limiting the discussion groups to five persons, whereas focus group methodology is often described as favoring group sizes closer to 8–12 participants (e.g., Vaughn, 96, Sage Pub), with possible consequences for the breadth of interaction and diversity of viewpoints; The manuscript would benefit from specifying the methodological referential used to justify this choice, and clarifying whether these were considered full focus groups or smaller breakout groups within a larger focus-group session. 4/ In the Analysis of the FGDs subsection, the thresholds “>50%” and “≤15%” are presented as decision rules for “retain,” “adjust,” and “omit,” but their applicability to this specific focus-group item-refinement setting remains unclear since the rules are borrowed from another consensus context; The manuscript would benefit from adding one concise explanation of why these thresholds were considered suitable for this study design and dataset. 5/ In the Introduction and Discussion, the manuscript alternates between the terms “broad health,” “Positive Health,” “Context-sensitive Positive Health Questionnaire,” and “Capability Approach,” without always specifying whether these terms refer to the same construct, a framework, or a measurement target; The manuscript would benefit from defining these terms once and using them with stricter consistency throughout. Wishing you every success in the subsequent editorial stages ! ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: Yes: Arthur Trognon ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 2 |
|
Dear Dr. Boelens, publication criteria and not, for example, on novelty or perceived impact. Please submit your revised manuscript by Jul 04 2026 11:59PM. If you will need more time than this to complete your revisions, please reply to this message or contact the journal office at plosone@plos.org. When you're ready to submit your revision, log on to https://www.editorialmanager.com/pone/ and select the 'Submissions Needing Revision' folder to locate your manuscript file.
If you would like to make changes to your financial disclosure, please include your updated statement in your cover letter. Guidelines for resubmitting your figure files are available below the reviewer comments at the end of this letter. If applicable, we recommend that you deposit your laboratory protocols in protocols.io to enhance the reproducibility of your results. Protocols.io assigns your protocol its own identifier (DOI) so that it can be cited independently in the future. For instructions see: https://journals.plos.org/plosone/s/submission-guidelines#loc-laboratory-protocols. Additionally, PLOS ONE offers an option for publishing peer-reviewed Lab Protocol articles, which describe protocols hosted on protocols.io. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols. As the corresponding author, your ORCID iD is verified in the submission system and will appear in the published article. PLOS supports the use of ORCID, and we encourage all coauthors to register for an ORCID iD and use it as well. Please encourage your coauthors to verify their ORCID iD within the submission system before final acceptance, as unverified ORCID iDs will not appear in the published article. Only the individual author can complete the verification step; PLOS staff cannot verify ORCID iDs on behalf of authors. We look forward to receiving your revised manuscript. Kind regards, Shiming Hao, Ph.D. Guest Editor PLOS One Journal Requirements: 1. If the reviewer comments include a recommendation to cite specific previously published works, please review and evaluate these publications to determine whether they are relevant and should be cited. There is no requirement to cite these works unless the editor has indicated otherwise. 2. Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice. Reviewers' comments: Reviewer's Responses to Questions Comments to the Author Reviewer #2: All comments have been addressed Reviewer #3: All comments have been addressed ********** 2. Is the manuscript technically sound, and do the data support the conclusions??> Reviewer #2: Partly Reviewer #3: Yes ********** 3. Has the statistical analysis been performed appropriately and rigorously? -->?> Reviewer #2: Yes Reviewer #3: Yes ********** 4. Have the authors made all data underlying the findings in their manuscript fully available??> The PLOS Data policy Reviewer #2: No Reviewer #3: Yes ********** 5. Is the manuscript presented in an intelligible fashion and written in standard English??> Reviewer #2: Yes Reviewer #3: Yes ********** Reviewer #2: l46 The 'n=76' is misplaced and somewhat confusing as it occur after 'one interview'. If it refers to the number of participants it should go after 'stakeholders'? ll53 For the 'At the same time, views diverged' lacks clarity as to what happened in these results. Due to a lack of consensus were these items excluded? l87 Can you specify more clearly what is meant by 'no adequately validated questionnaires' as this is the crux of reasoning for why this study occured. What were the issues with these questionnaires? How does this research seek to address them? l93 It would be helpful to specify why it was not 'suitable'. l143 Specify who the 'experts' were. l154-158 Suggest list these numerically for structure and clarity, as they are currently a long wordy read. l195 What does 'memo' refer to? Does this mean the CPHQ lists of items? l207 What is Appendix S3 referring to? l219 As above - what are the memos referring to? l217 Clarify how the themes were determined? l222-232 This decision-making process seems unnecessarily complex and confusing, especially considering it was done per FDG and these groups ranged in size from 6 to 14 participants. Or were all groups combined and then these metrics were calculated? l322 What type of qualitative analysis was used? it is problematic that this is not clarified throughout the article. Were deductive or inductive approaches used? Who in the team has qualitative experience? Given the background of the core team, there seems to be significant potential for bias to occur- as noted by the authors. Table 2 - I appreciate why statistically you have used a Median and IQR for Age, but providing a Mean and Age Range would be clearer for the reader. l331 - missing the word 'see' before Appendix S5 l334 - typo for 'table' should be capitalised. Table 4 is very difficult to read. Suggest reformat in Landscape not Portrait. Table 4 - Item 3 (original) is very different to the Revision wording, to the extent it isn't measuring the same thing. What someone values is very different to what is important. Table 4 - Item 7 Revision seems highly problematic. Unless you have a severe spinal cord injury, everyone can move. The original item that denoted 'easily' was a much better descriptor of what the item seems to be trying to measure. l345 It would be helpful to specify who the experts were at this stage. l362 - Should read Table not table There are some issues with the 'expert' added items. Namely: Item 2 clearly describes achievement - it is not about meaning or belonging. Item 3 is poorly worded and relates to three different things - work, volunteering and 'informal care' which will most likely to jargon to a layperson. Similarly Item 4 sounds like psychological jargon with 'boundaries' and should be rephrased for a layperson. I also think it is problematic that the 'expert' group came in over the top of the community consultation and added their own preferred items and words in. It would have been more methodologically sound to do this prior to the community consultation, not afterwards. l381 The comment that the 'experts' felt that the CPHQ should be based on theory hence the use of Capability theory is interesting. Surely the CPHQ is based on Positive Health theory? l395 Shoud read Table not table 7 Table 7 should be for each of the final items, not only the Totals. The range of ratings for each item should also be provided. l403 Again should read Table not table 8 l413 It looks like 'times' is an error and should be 'items'. My comments above tend to be editorial, with some minor methodological issues. Essentially this is a long article on the item (re) development phase of a scale which now needs some good quantitative research done to it. A minor (? major) issue is I think the scale is misnamed. Its not at all about the contexts within which patients life their lives and deal with it's challenges. It is, in fact, entirely without context in the items, and the capability framework is about linguistic expression of capabilities, it is not at all about context. Given these concerns though, positive health is an important, slowly emerging concept, and a good scale to measure it well is a worthy endeavour. Reviewer #3: The authors carried out a very thorough revision and I am particularly satisfied with the final state of the manuscript. ********** what does this mean?). If published, this will include your full peer review and any attached files. If you choose “no”, your identity will remain anonymous but your review may still be made public. Do you want your identity to be public for this peer review? For information about this choice, including consent withdrawal, please see our Privacy Policy Reviewer #2: No Reviewer #3: Yes: Dr. Arthur Trognon ********** [NOTE: If reviewer comments were submitted as an attachment file, they will be attached to this email and accessible via the submission site. Please log into your account, locate the manuscript record, and check for the action link "View Attachments". If this link does not appear, there are no attachment files.] To ensure your figures meet our technical requirements, please review our figure guidelines: https://journals.plos.org/plosone/s/figures You may also use PLOS’s free figure tool, NAAS, to help you prepare publication quality figures: https://journals.plos.org/plosone/s/figures#loc-tools-for-figure-preparation. NAAS will assess whether your figures meet our technical requirements by comparing each figure against our figure specifications. |
| Revision 3 |
|
Stakeholder and end-user perspectives to refine the Context-sensitive Positive Health Questionnaire (CPHQ) to measure broad health PONE-D-25-39699R3 Dear Dr. Mirte Boelens, We’re pleased to inform you that your manuscript has been judged scientifically suitable for publication and will be formally accepted for publication once it meets all outstanding technical requirements. Within one week, you’ll receive an e-mail detailing the required amendments. When these have been addressed, you’ll receive a formal acceptance letter and your manuscript will be scheduled for publication. An invoice will be generated when your article is formally accepted. Please note, if your institution has a publishing partnership with PLOS and your article meets the relevant criteria, all or part of your publication costs will be covered. Please make sure your user information is up-to-date by logging into Editorial Manager at Editorial Manager® and clicking the ‘Update My Information' link at the top of the page. For questions related to billing, please contact billing support. If your institution or institutions have a press office, please notify them about your upcoming paper to help maximize its impact. If they’ll be preparing press materials, please inform our press team as soon as possible -- no later than 48 hours after receiving the formal acceptance. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. Kind regards, Shiming Hao, Ph.D. Guest Editor PLOS One |
| Formally Accepted |
|
PONE-D-25-39699R3 PLOS One Dear Dr. Boelens, I'm pleased to inform you that your manuscript has been deemed suitable for publication in PLOS One. Congratulations! Your manuscript is now being handed over to our production team. At this stage, our production department will prepare your paper for publication. This includes ensuring the following: * All references, tables, and figures are properly cited * All relevant supporting information is included in the manuscript submission, * There are no issues that prevent the paper from being properly typeset You will receive further instructions from the production team, including instructions on how to review your proof when it is ready. Please keep in mind that we are working through a large volume of accepted articles, so please give us a few days to review your paper and let you know the next and final steps. Lastly, if your institution or institutions have a press office, please let them know about your upcoming paper now to help maximize its impact. If they'll be preparing press materials, please inform our press team within the next 48 hours. Your manuscript will remain under strict press embargo until 2 pm Eastern Time on the date of publication. For more information, please contact onepress@plos.org. You will receive an invoice from PLOS for your publication fee after your manuscript has reached the completed accept phase. If you receive an email requesting payment before acceptance or for any other service, this may be a phishing scheme. Learn how to identify phishing emails and protect your accounts at https://explore.plos.org/phishing. If we can help with anything else, please email us at customercare@plos.org. Thank you for submitting your work to PLOS One and supporting open access. Kind regards, PLOS ONE Editorial Office Staff on behalf of Professor Shiming Hao Guest Editor PLOS One |
Open letter on the publication of peer review reports
PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.
We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.
Learn more at ASAPbio .